Form 10-Q Kiniksa Pharmaceuticals For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Kiniksa (KNSA) PT Raised to $35 at Evercore ISI
October 29, 2024 4:23 PM EDTEvercore ISI analyst Liisa Bayko raised the price target on Kiniksa (NASDAQ: KNSA) to $35.00 (from $30.00) while maintaining a Outperform rating.
The analyst comments "KNSA has a solid Q with $112.2M Arcalyst sales slightly beating consensus of $111.5M. KNSA raised... More
